modelJ01DB04

Diagram of J01DB04

Extends from Pharmacokinetic.Models.PK_2C.

Information

name:Cefazolin
ATC code:J01DB04
route:intravenous
compartments:2
dosage:1000mg
volume of distribution:9.3L
clearance:3.3L/h
other parameters in model implementation

Cefazolin is a first-generation cephalosporin antibiotic used primarily for the treatment of a variety of bacterial infections, including those of the skin, bone, joint, respiratory tract, urinary tract, and for surgical prophylaxis. It is an approved drug widely used in clinical practice due to its efficacy and safety profile.

Pharmacokinetics

Pharmacokinetic parameters in healthy adult volunteers following a single intravenous bolus dose.

References

  1. Šantavý, P, et al., & Urbánek, K (2022). Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation. Antibiotics (Basel, Switzerland) 11(11) –. DOI:10.3390/antibiotics11111582 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36358235

  2. Asada, M, et al., & Yasuhara, M (2021). Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery. European journal of clinical pharmacology 77(5) 735–745. DOI:10.1007/s00228-020-03045-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33211137

  3. Alli, A, et al., & Roberts, JA (2023). Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery. PloS one 18(9) e0291425–None. DOI:10.1371/journal.pone.0291425 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37729151

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)